Risk of Cardiovascular Events Associated With Selective COX-2 Inhibitors.
Mukherjee, Debabrata MD; Nissen, Steven E. MD; Topol, Eric J. MD
[Article] JAMA. 286(8):954-959, August 22/29, 2001.

(Format: HTML)